The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Research Report 2025
Synopsis
Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.
The global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market was valued at US$ 3562.7 million in 2023 and is anticipated to reach US$ 6147.6 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics.
Report Scope
The Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics
Segment by Type
Real Time PCR
DNA/RNA Purification
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.
The global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market was valued at US$ 3562.7 million in 2023 and is anticipated to reach US$ 6147.6 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics.
Report Scope
The Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics
Segment by Type
Real Time PCR
DNA/RNA Purification
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Real Time PCR
1.2.3 DNA/RNA Purification
1.3 Market by Application
1.3.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Perspective (2019-2030)
2.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Growth Trends by Region
2.2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Dynamics
2.3.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industry Trends
2.3.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
2.3.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Challenges
2.3.4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players by Revenue
3.1.1 Global Top Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue
3.4 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Concentration Ratio
3.4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue in 2023
3.5 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Key Players Head office and Area Served
3.6 Key Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Solution and Service
3.7 Date of Enter into Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Breakdown Data by Type
4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Breakdown Data by Application
5.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2019-2030)
6.2 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
6.4 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2019-2030)
7.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2019-2030)
9.2 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Atlas Genetics
11.2.1 Atlas Genetics Company Detail
11.2.2 Atlas Genetics Business Overview
11.2.3 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.2.4 Atlas Genetics Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2019-2024)
11.2.5 Atlas Genetics Recent Development
11.3 Cepheid
11.3.1 Cepheid Company Detail
11.3.2 Cepheid Business Overview
11.3.3 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.3.4 Cepheid Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2019-2024)
11.3.5 Cepheid Recent Development
11.4 Fluxergy
11.4.1 Fluxergy Company Detail
11.4.2 Fluxergy Business Overview
11.4.3 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.4.4 Fluxergy Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2019-2024)
11.4.5 Fluxergy Recent Development
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Company Detail
11.5.2 Roche Diagnostics Business Overview
11.5.3 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
11.5.4 Roche Diagnostics Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2019-2024)
11.5.5 Roche Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
